Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kushner

Showing results (101-110 of 245) with videos related to

Pageof 25
Sort By:
JCO Precision Oncology|July 10, 2025
Clinical Significance of <i>TERT</i> Promoter Mutations in NeuroblastomaNatasha Persaud, Gunes Gundem, Brian H Kushner, et al.
American Journal of Medical Genetics|September 19, 1998
Transition to young adulthood in Ullrich-Turner syndrome: neurodevelopmental changesS M Romans, G Stefanatos, D P Roeltgen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Management and outcome of stage 3 neuroblastomaShakeel Modak, Brian H Kushner, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|January 24, 2017
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II studyShakeel Modak, Brian H Kushner, Ellen Basu, et al.
Medical and Pediatric Oncology|January 1, 1990
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitroB H Kushner, S C Gulati, R J O'Reilly, et al.
Medical and Pediatric Oncology|July 9, 1999
Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcomaT E Merchant, B H Kushner, J M Sheldon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastomaIrene Y Cheung, M Serena Lo Piccolo, Brian H Kushner, et al.
American Journal of Nephrology|January 1, 1992
Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis timesJ P Capelli, H Kushner, T Camiscioli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1994
Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease careJ P Capelli, H Kushner, T C Camiscioli, et al.
Journal of Pediatric Hematology/Oncology|November 16, 2004
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentationKim Kramer, Brian H Kushner, Jeffrey C Allen, et al.
Pageof 25

Showing results (101-110 of 245) with videos related to

Sort By:
Pageof 25
JCO Precision Oncology|July 10, 2025
Clinical Significance of <i>TERT</i> Promoter Mutations in NeuroblastomaNatasha Persaud, Gunes Gundem, Brian H Kushner, et al.
American Journal of Medical Genetics|September 19, 1998
Transition to young adulthood in Ullrich-Turner syndrome: neurodevelopmental changesS M Romans, G Stefanatos, D P Roeltgen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Management and outcome of stage 3 neuroblastomaShakeel Modak, Brian H Kushner, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|January 24, 2017
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II studyShakeel Modak, Brian H Kushner, Ellen Basu, et al.
Medical and Pediatric Oncology|January 1, 1990
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitroB H Kushner, S C Gulati, R J O'Reilly, et al.
Medical and Pediatric Oncology|July 9, 1999
Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcomaT E Merchant, B H Kushner, J M Sheldon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastomaIrene Y Cheung, M Serena Lo Piccolo, Brian H Kushner, et al.
American Journal of Nephrology|January 1, 1992
Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis timesJ P Capelli, H Kushner, T Camiscioli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1994
Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease careJ P Capelli, H Kushner, T C Camiscioli, et al.
Journal of Pediatric Hematology/Oncology|November 16, 2004
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentationKim Kramer, Brian H Kushner, Jeffrey C Allen, et al.
Pageof 25